Trial Profile
Phase II Study of Heart Polypill in Primary Prevention of Cardiovascular Disease - Safety and Efficacy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Aspirin/hydrochlorothiazide/enalapril/atorvastatin (Primary)
- Indications Cardiovascular disorders; Embolism and thrombosis
- Focus Therapeutic Use
- 01 Aug 2010 Results published in the International Journal of Clinical Practice.
- 24 Jun 2009 Trial phase changed from III to II, additional lead trial centre and investigator as reported by ClinicalTrials.gov.
- 24 Jun 2009 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.